中性粒细胞弹性酶选择性地杀死癌细胞并减弱瘤发生
Chang Cui1, Kasturi Chakraborty2, Xu Anna Tang2
1Committee on Cancer Biology, The University of Chicago, Chicago, IL 60637, USA; Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.
Cell
|May 8, 2021
概括
中性粒细胞弹性酶 (ELANE) 通过向CD95死亡域来选择性地杀死各种癌细胞,从而提供一种潜在的广泛的抗癌疗法,对宿主有最小的毒性. 这种先天的免疫酶对癌症治疗具有前途.
科学领域:
- 免疫学
- 癌症学
- 生物化学
背景情况:
- 癌症的遗传多样性和宿主细胞相似性挑战了广泛的治疗发展.
- 这种天生的免疫系统有选择性地向癌细胞的能力在很大程度上还未被探索.
研究的目的:
- 调查天生的免疫力,特别是中性粒细胞弹性酶 (ELANE) 作为广泛的抗癌药物的潜力.
- 阐明ELANE选择性地消除癌细胞的机制.
主要方法:
- 人类和小鼠中性粒细胞功能的分析.
- 对各种癌细胞类型的中性粒细胞弹性酶 (ELANE) 活性进行研究.
- ELANE的作用机制涉及CD95死亡域和基因素H1异型.
- 评估ELANE在原发性瘤生长和非体效应中的疗效.
- 评估猪胰腺弹性酶作为一种治疗选择.
主要成果:
- 人类中性粒细胞释放活性ELANE,选择性地杀死多种癌细胞,同时保留非癌细胞.
- ELANE释放CD95死亡域,与素H1异型相互作用以消除癌细胞.
- ELANE治疗减少了原发性瘤的生长,并诱导了 CD8+ T 细胞介导的抗远程转移作用.
- 猪胰腺弹性酶对瘤衍生蛋白酶抑制剂的疗效和耐药性得到了增强.
结论:
- ELANE对基因多样化的癌细胞具有选择性细胞毒性,对宿主有最小的毒性.
- ELANE的机制为广泛的癌症治疗提供了一种新的治疗策略.
- ELANE及其类似物是开发新型抗癌疗法的有希望的候选药物.
相关概念视频
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
Mitogens and the Cell Cycle
7.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Replicative Cell Senescence
4.0K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.0K
Cells of the Innate Immune Response
7.4K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
7.4K
Cancer Stem Cells and Tumor Maintenance
5.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K


